Cleared Traditional

K092388 - DURAGEN PLUS DURAL REGENERATION MATRIX- SPINAL MATRIX, MODEL DP2013SM, INTEGRA SPINAL MEND DURAL REGENERATION MATRIX, MO (FDA 510(k) Clearance)

Jan 2010
Decision
169d
Days
Class 2
Risk

K092388 is an FDA 510(k) clearance for the DURAGEN PLUS DURAL REGENERATION MATRIX- SPINAL MATRIX, MODEL DP2013SM, INTEGRA SPINAL MEND DURAL REGENERATION MATRIX, MO. This device is classified as a Dura Substitute (Class II - Special Controls, product code GXQ).

Submitted by Integra LifeSciences Corporation (Planisboro, US). The FDA issued a Cleared decision on January 21, 2010, 169 days after receiving the submission on August 5, 2009.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5910.

Submission Details

510(k) Number K092388 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 05, 2009
Decision Date January 21, 2010
Days to Decision 169 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code GXQ — Dura Substitute
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.5910